- The goal of this strategy is to enable patients to gain functional independence.
- It will also be useful to reduce the length of hospital stay, costs and complications from nosocomial infections.
- Oxygen therapy will benefit patients with asthma, pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), cancer, tuberculosis, pneumonia, influenza, and COVID-19.
The pandemic is at one of its lowest points, although it is still too hasty to consider that it is over. Although the truth is that over the last three years many lessons have been obtained. In this sense, one of the most important is the oxygen therapy as a treatment for patients with Covid-19.
What does it consist of?
According to Medline Plus, it is a treatment that delivers extra oxygen for a person to breathe. It is also called supplemental oxygen. Only your health professional can indicate this type of care. Although some people only need it for a short period of time, in other cases it may be necessary in the long term.
But now the most important thing is that the National Institute of Respiratory Diseases (INER) “Ismael Cosío Villegas” of the Ministry of Health announced that it will provide, for the first time, Home oxygen therapy for patients with respiratory diseases. In this way they can continue with the treatment at home to improve their quality of life and prevent clinical deterioration caused by respiratory failure.
These devices will allow patients to acquire functional independence, integrate into family, work and social life. It will also be useful for reduce the length of hospital stay and the costs and complications of nosocomial infections.
Likewise, physical spaces are freed up for other patients who need to be hospitalized, reducing the impact on the economy of vulnerable families by avoiding treatment expenses for the direct purchase or sale of equipment or devices.
Diseases for which oxygen therapy is recommended
At the donation ceremony for 175 oxygen concentrators by the Linde Mexico Foundation through Medigas, to the National Institute of Respiratory Diseases (INER) “Ismael Cosío Villegas”, its director, Jorge Salas Hernández, explained that the oxygen therapy service will benefit patients with asthma, pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), cancer, tuberculosis, pneumonia , influenza and COVID-19.
During the ceremony held in the Auditorium “Dr. Fernando Rébora Gutiérrez” from the institute, Salas Hernández highlighted that the collaboration with the company is more than 20 years old, through the supply and monitoring of the oxygen network that the institute has used as therapy in patients with acute and chronic respiratory diseases. , especially in the health contingency.
As an example of this, he said that the Linde company arranged through a contract with the National Institute of Health for Well-being (Insabi) two mobile oxygen units that allowed INER to have this supply for 200 fans that were installed with the hospital conversion.
It is worth mentioning that, during the pandemic, through the installation and implementation of the central medical gas network, supply, monitoring and connection equipment, and mobile oxygen units, critical care care was provided to patients with COVID-19 who developed severe respiratory disease.
Three years after the detection of the first case of COVID-19 in Mexico, the general director of INER reiterated that this collaboration will help the institute continue to serve the people who need it most.
He explained that the use of this medical device is not only used in periods of acute respiratory failure, but also during follow-up and continuity of out-of-hospital medical treatment of stable patients who continue their recovery at home.
Meanwhile, the medical director of INER, Justino Regalado Pineda, explained that collaboration is one of the successful strategies to get ahead in the event of health crises, which are inevitable.
Also read:
Cofepris recommendations for the use of oxygen therapy in Covid-19 patients
3 new WHO guidelines for the management of Covid-19 patients
Adverse effects of the 5 drugs against Covid-19 authorized by the SSa